Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-27

Clinical Trial Update: Benign Prostatic Hyperplasia and Ischemic Heart DIsease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Benign Prostatic Hyperplasia and Ischaemic Heart Disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: I.M. Sechenov First Moscow State Medical University | Conditions: Ischaemic Heart Disease (IHD), Benign Prostatic Hyperplasia (BPH) | Phase 4 | Status: COMPLETED